Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022239

Expand all

SUMAVEL DOSEPRO (SUMATRIPTAN SUCCINATE)
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
Marketing Status: Discontinued
Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: SUMAVEL DOSEPRO
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022239
Product Number: 002
Approval Date: Nov 26, 2013
Applicant Holder Full Name: ENDO VENTURES LTD IRELAND
Marketing Status:  Discontinued
Patent and Exclusivity Information
SUMAVEL DOSEPRO (SUMATRIPTAN SUCCINATE)
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Marketing Status: Discontinued
Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: SUMAVEL DOSEPRO
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022239
Product Number: 001
Approval Date: Jul 15, 2009
Applicant Holder Full Name: ENDO VENTURES LTD IRELAND
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English